• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Rapid SARS-CoV-2 testing in primary material based on a novel multiplex RT-LAMP assay

tetano

Editor, Senior Moderator
PLoS One


. 2020 Nov 2;15(11):e0238612.
doi: 10.1371/journal.pone.0238612. eCollection 2020.
Rapid SARS-CoV-2 testing in primary material based on a novel multiplex RT-LAMP assay


Bernhard Schermer[SUP] 1 2 3 [/SUP], Francesca Fabretti[SUP] 1 2 3 [/SUP], Maximilian Damagnez[SUP] 4 [/SUP], Veronica Di Cristanziano[SUP] 4 [/SUP], Eva Heger[SUP] 4 [/SUP], Sita Arjune[SUP] 1 2 3 [/SUP], Nathan A Tanner[SUP] 5 [/SUP], Thomas Imhof[SUP] 2 6 [/SUP], Manuel Koch[SUP] 2 6 [/SUP], Alim Ladha[SUP] 7 8 9 10 [/SUP], Julia Joung[SUP] 7 8 9 10 [/SUP], Jonathan S Gootenberg[SUP] 9 11 [/SUP], Omar O Abudayyeh[SUP] 9 11 [/SUP], Volker Burst[SUP] 1 12 [/SUP], Feng Zhang[SUP] 7 8 9 10 11 13 [/SUP], Florian Klein[SUP] 2 4 14 [/SUP], Thomas Benzing[SUP] 1 2 3 [/SUP], Roman-Ulrich M?ller[SUP] 1 2 3 [/SUP]



Affiliations
Free article

Abstract

Background: Rapid and extensive testing of large parts of the population and specific subgroups is crucial for proper management of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and decision-making in times of a pandemic outbreak. However, point-of-care (POC) testing in places such as emergency units, outpatient clinics, airport security points or the entrance of any public building is a major challenge. The need for thermal cycling and nucleic acid isolation hampers the use of standard PCR-based methods for this purpose.
Methods: To avoid these obstacles, we tested PCR-independent methods for the detection of SARS-CoV-2 RNA from primary material (nasopharyngeal swabs) including reverse transcription loop-mediated isothermal amplification (RT-LAMP) and specific high-sensitivity enzymatic reporter unlocking (SHERLOCK).
Results: Whilst specificity of standard RT-LAMP assays appears to be satisfactory, sensitivity does not reach the current gold-standard quantitative real-time polymerase chain reaction (qPCR) assays yet. We describe a novel multiplexed RT-LAMP approach and validate its sensitivity on primary samples. This approach allows for fast and reliable identification of infected individuals. Primer optimization and multiplexing helps to increase sensitivity significantly. In addition, we directly compare and combine our novel RT-LAMP assays with SHERLOCK.
Conclusion: In summary, this approach reveals one-step multiplexed RT-LAMP assays as a prime-option for the development of easy and cheap POC test kits.
 
Back
Top Bottom